Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
latest_posts
- 1
Influencers are selling a delusional fantasy of being postpartum. Why is it so easy to believe? - 2Did Japan’s PM Actually Back the Memecoin Bearing Her Name?
- 31st human missions to Mars should hunt for signs of life, report says
- 4Major railway disruptions persist as Germany braces for more snow
- 5The Craft of Do-It-Yourself Home Stylistic layout: Change Your Space
- PHOTO ESSAY: Scientists trying to unravel one of the body's biggest mysteries
- Moldova says Russian drones violated airspace
- Dozens of hidden star streams found in the outskirts of our Milky Way galaxy
- 'Every day I planned an escape': Ariel Cunio shares details of Hamas captivity
- Eleven Creations And Developments That Steered History
- France bans Muslim gathering citing risk to participants
- 2025 Yachting Editors' Choice Awards: Yachts
- Startled Venezuelans express relief but also fear after Maduro arrest
- Boeing's troubled capsule won't carry astronauts on next space station flight
